Short answer · Medically reviewed summary · Last updated: 2026-05-08
TNF Receptor Associated Periodic Syndrome (TRAPS) is an autoinflammatory condition caused by autosomal dominant mutations in the TNFRSF1A gene, which leads to persistent activation of the body's inflammatory response. Unlike autoimmune diseases where the body attacks itself, TNF Receptor Associated Periodic Syndrome is a genetic "glitch" in the signaling pathway that regulates inflammation, causing recurrent fevers and systemic pain. What genetic factors cause TNF Receptor Associated Periodic Syndrome? TNF Receptor Associated Periodic Syndrome is caused by a mutation in the TNFRSF1A gene on chromosome 12.
TNF Receptor Associated Periodic Syndrome (TRAPS) is an autoinflammatory condition caused by autosomal dominant mutations in the TNFRSF1A gene, which leads to persistent activation of the body's inflammatory response. Unlike autoimmune diseases where the body attacks itself, TNF Receptor Associated Periodic Syndrome is a genetic "glitch" in the signaling pathway that regulates inflammation, causing recurrent fevers and systemic pain.
TNF Receptor Associated Periodic Syndrome is caused by a mutation in the TNFRSF1A gene on chromosome 12. This gene provides instructions for creating the TNF receptor, a protein that sits on cell surfaces to help manage inflammation. When this receptor is mutated, it fails to "turn off" properly, causing the body to remain in a state of high alert even without an infection to fight. Because it is inherited in an autosomal dominant pattern, a person only needs one copy of the mutated gene from one parent to develop TNF Receptor Associated Periodic Syndrome.
While the underlying cause of TNF Receptor Associated Periodic Syndrome is strictly genetic, the frequency and severity of flare-ups can be influenced by external factors. Patients often report that their symptoms are triggered or worsened by:
The primary genetic cause is well-documented, but researchers are still studying why the clinical presentation of TNF Receptor Associated Periodic Syndrome varies so significantly between individuals, even those within the same family. Current research focuses on "modifier genes" and how they might influence the intensity of the inflammatory response. Understanding these mechanisms is critical for developing more targeted, personalized therapies for patients living with this rare condition.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.